Moderne Therapie des Typ-1-Diabetes: Pumpentherapie mit Insulinanaloga – Indikationen, Daten zur Handhabung und Ausblicke
N.N. · Diabetologie und Stoffwechsel · 2017 · Heft 01 · S. 56-66
Bibliografische Angaben
Zusammenfassung
Abstract Continuous subcutaneous insulin infusion using a pump (CSII) is started in adults with type 1 diabetes after previous attempts with multiple daily insulin injections (MDI) and in children often shortly after they have been diagnosed with diabetes. A prerequisite of the success of CSII is the motivation and reliability of patients (or – in the case of children – of their parents) as well as a proper training. CSII has a broad overall spectrum of indications. Guidelines for determining the indication for pump therapy describe information on HbA1c, the dawn phenomenon, pregnancy and episodes of hypoglycaem…